NF-κB
In mammals, there are five members of the transcription factor NF-κB family: RelA (p65), RelB and c-Rel, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. All NF-κB proteins share a Rel homology domain responsible for DNA binding and dimerization. Bacterial and viral infection, inflammatory cytokines and engagement of antigen receptors all elicit NF-κB activation, which highlights the crucial role of this transcription factor in the orchestration of immunity. The range of NF-κB-inducing stimuli further extends to physical, physiological and oxidative stresses, and its additional functions include regulation of cell differentiation, proliferation and survival. As a consequence, dysregulation of NF-κB activity is linked to inflammatory disorders, autoimmune and metabolic diseases, as well as cancer.
Overall, two main NF-κB-activating pathways exist in cells. The canonical pathway is induced by most physiological NF-κB stimuli; for example, signals emanating from cytokine receptors, such as the tumor necrosis factor receptor (TNFR) and interleukin 1 (IL-1) receptor (IL-1R), antigen receptors and pattern-recognition receptors, including Toll-like receptor 4 (TLR4). The canonical pathway is defined as dependent on IKKβ and NEMO and leads mainly to phosphorylation of IκBα and nuclear translocation of mostly p65-containing heterodimers. In contrast, the noncanonical pathway depends on IKKα-mediated phosphorylation of p100 associated with RelB and leads to partial processing of p100 and the generation of p52-RelB complexes. Noncanonical signaling is induced by specific members of the TNF cytokine family, such as CD40 ligand, BAFF and lymphotoxin-β2.
References
1.Oeckinghaus A,et al. Nat Immunol. 2011;12(8):695–708.
Overall, two main NF-κB-activating pathways exist in cells. The canonical pathway is induced by most physiological NF-κB stimuli; for example, signals emanating from cytokine receptors, such as the tumor necrosis factor receptor (TNFR) and interleukin 1 (IL-1) receptor (IL-1R), antigen receptors and pattern-recognition receptors, including Toll-like receptor 4 (TLR4). The canonical pathway is defined as dependent on IKKβ and NEMO and leads mainly to phosphorylation of IκBα and nuclear translocation of mostly p65-containing heterodimers. In contrast, the noncanonical pathway depends on IKKα-mediated phosphorylation of p100 associated with RelB and leads to partial processing of p100 and the generation of p52-RelB complexes. Noncanonical signaling is induced by specific members of the TNF cytokine family, such as CD40 ligand, BAFF and lymphotoxin-β2.
References
1.Oeckinghaus A,et al. Nat Immunol. 2011;12(8):695–708.
Apoptosis
NF-κB
-
4-methoxylonchocarpin
产品货号 : M37846
cas no: 51589-67-4
4-Methoxylonchocarpin 是一种口服有效的抗炎剂。4-Methoxylonchocarpin 抑制 LPS 与 Toll 样受体 4 (TLR4) 的结合来抑制 NF-κB 活化以及肿瘤坏死因子 (TNF) 和白细胞介素 IL-6 的表达。4-Methoxylonchocarpin 还抑制 TGF-beta 激活激酶 1 的磷酸化和 2,4,6-三硝基苯磺酸 (TNBS) 诱导的 IL-1β、IL-17A 和 TNF 表达。4-Methoxylonchocarpin 能改善 TNBS 诱导的结肠炎小鼠模型。 -
Scandoside
产品货号 : M37776
cas no: 18842-99-4
Scandoside 是一种可从 Paederia scandens 的环烯醚萜苷中分离得到的天然产物。 -
Cynaropicrin
产品货号 : M37734
cas no: 35730-78-0
Cynaropicrin 是一种倍半萜内酯,可以抑制肿瘤坏死因子 (TNF-α) 的释放,在鼠和人巨噬细胞的 IC50 值分别为 8.24 和 3.18 μM。 Cynaropicrin 也抑制软骨降解因子 (MMP13) 的增加并抑制 NF-κB的信号传导。 -
AP-1/NF-κB activation inhibitor 1
产品货号 : M37648
cas no: 188936-12-1
AP-1/NF-κB activation inhibitor 1 是一种有效的 AP-1 和NF-κB 介导的转录激活抑制剂(IC50=1 μM),不阻断 β-actin 启动子驱动的基础转录。AP-1/NF-κB activation inhibitor 1 对受刺激细胞产生IL-2和IL-8水平有相似的抑制作用。 -
Antiproliferative agent-22
产品货号 : M37583
cas no: 1374305-45-9
Antiproliferative agent-22 (compound 2) 是一种抗癌剂。Antiproliferative agent-22 对 MCF-7、MDA-MB-231 和 MDA-MB-468 细胞具有抗增殖活性,IC50 值分别为 6.2 μM、3.3 μM 和 3.3 μM。